CRBU Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Caribou Biosciences Inc

Watchlist Manager

Watchlist

Price: 2.1 USD 5.53%

Market Cap: $202.9m

	Caribou Biosciences Inc NASDAQ:CRBU	US
	B.P. Marsh & Partners PLC LSE:BPM	UK
S	Sagility India Ltd NSE:SAGILITY	IN
	Pangaea Logistics Solutions Ltd NASDAQ:PANL	US
	Primo Water Corp TSX:PRMW	US
Y	Yellow Cake PLC LSE:YCA	JE
	Bellring Brands Inc NYSE:BRBR	US
	Euroseas Ltd NASDAQ:ESEA	GR
	Sumitomo Mitsui Financial Group Inc TSE:8316	JP
	LNA Sante SA PAR:LNA	FR
	Inovio Pharmaceuticals Inc NASDAQ:INO	US
	Dynex Capital Inc NYSE:DX	US

Profitability Summary

Caribou Biosciences Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-1.220%

Negative 3Y Average Operating Margin

-1.053%

Declining Operating Margin

-795% > -1.220%

Negative Net Margin

-1.327%

Negative 3Y Average Net Margin

-1.015%

Declining Net Margin

-738% > -1.327%

Negative Free Cash Flow Margin

-1.007%

Negative 3Y Average Free Cash Flow Margin

-901%

Declining Free Cash Flow Margin

-715% > -1.007%

Negative ROE

-79%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-157%

Declining ROIC

-113% > -206%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.